Search Results - "Bubanović, Gordana"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2
  3. 3

    Size, edge, and stage of NSCLC determine the release of CYFRA 21-1 in bloodstream by Sertić Milić, Helga, Franjević, Ana, Bubanović, Gordana, Marušić, Ante, Nikolić, Igor, Puljić, Igor

    Published in Wiener Klinische Wochenschrift (01-06-2015)
    “…Summary Background The computed tomography (CT) is the “golden standard” for the assessment of lung cancer progression due to its ability to clearly display…”
    Get full text
    Journal Article
  4. 4

    Differences in initial NSE levels in malignant and benign diseases of the thoracic wall by Franjević, Ana, Pavićević, Radomir, Bubanović, Gordana

    Published in Clinical laboratory (Heidelberg) (2012)
    “…Neuron-specific enolase (NSE) is widely used to follow-up patients with small cell lung cancer (SCLC). Since the NSE level can be influenced by a broad range…”
    Get more information
    Journal Article
  5. 5

    ICTP in bone metastases of lung cancer by Franjević, Ana, Pavićević, Radomir, Bubanović, Gordana

    Published in Collegium antropologicum (01-03-2011)
    “…Bone metastases often appear in advanced stages of lung cancer. They are the result of modulation of bone metabolism by tumor cells that migrated into bone…”
    Get more information
    Journal Article
  6. 6

    Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics by Bubanović, Gordana, Pavićević, Radomir, Franjević, Ana

    Published in Collegium antropologicum (01-12-2008)
    “…The standardisation process consisted of determining tumour marker levels in all relevant population groups which are connected with the biology of the marker…”
    Get more information
    Journal Article
  7. 7

    CYFRA 21-1 in non-small cell lung cancer--standardisation and application during diagnosis by Pavićević, Radomir, Bubanović, Gordana, Franjević, Ana, Stancić-Rokotov, Dinko, Samarzija, Miroslav

    Published in Collegium antropologicum (01-06-2008)
    “…There is no ideal tumour marker at present. The clinical application of CYFRA 21-1 is possible once a thorough standardisation process is carried out…”
    Get more information
    Journal Article